NASDAQ:COYA | Cash Flow Statement | Coya Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$6.64M
2026-03-31-$7.21M-$6.21M-$885,000.00$11M
2025-12-31-$5.71M-$1.01M-$648,606.00$20.35M
2025-09-30-$2.12M
2025-06-30-$6.09M
2025-03-31-$7.31M-$2.83M$19,137.00
2024-12-31-$2.92M-$2.41M$0.00$9.69M
2024-09-30-$4.02M
2024-06-30-$2.89M
2024-03-31-$5.05M$2.15M-$25,000.00$1.24M
2023-12-31$1.27M-$2.24M-$193,186.00$24.17M
2023-09-30-$3.42M
2023-06-30-$3.1M
2023-03-31-$2.74M-$3.86M$14.25M
2022-12-31-$3.11M-$2.22M-$390,000.00-$104,071.00
2022-09-30-$4.02M
2022-06-30-$3.41M
2022-03-31-$1.7M-$1.98M-$65,227.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$21.23M-$10.74M-$1.16M$20.39M
2024-12-31-$14.88M-$10.29M-$25,000.00$16.03M
2023-12-31-$7.99M-$11.19M-$543,186.00$38.43M
2022-12-31-$12.24M-$7.24M-$525,000.00$9.36M
2021-12-31-$4.89M-$3.9M-$136,804.00-$340,584.00